EQV VENTURES ACQUISITION CORP. II
- Market cap
- 602.60M
- P/E (TTM)i
- 14.75
- P/Bi
- 1.31
- EPSi
- 0.26
- Div yieldi
- 0.00%
- 52W posi
- 95%
Anonymous reader poll. Unscientific, not investment advice.
Valuation each multiple against its own 5-year range
Vs. peers Shell Companies
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| EQV VENTURES ACQUISITION CORP. II (EVAC) | 602.60M | 14.75 | 1.31 | 0.00% |
| Vylor Inc (VYLR) | 48.70B | 102.95 | 3.21 | 0.00% |
| ARMADA ACQUISITION CORP II (XRPN) | 790.07M | 252.63 | 3.49 | 0.00% |
| DRUGS MADE IN AMERICA ACQ II CORP (DMII) | 649.10M | 34.90 | 1.31 | 0.00% |
| Churchill Capital Corp XI (CCXI) | 626.07M | 0.00 | 2.33 | 0.00% |
| Bain Capital GSS Investment (BCSS) | 596.85M | 0.00 | 1.30 | 0.00% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 0.1% above Morningstar's fair value estimate.
Fair value
EQV Ventures Acquisition Corp II receives a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a price consistent with our quantitative fair value estimate, which has a high uncertainty rating.
The firm's lack of profitability undermines our estimated valuation. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. For example, the firm's earnings yield of 2.9% ranks in the bottom 45% globally. The earnings generated by the company relative to its share price is concerning, which contributes to our balanced fair value estimate.
Alternatively, the firm's valuation metrics are reassuring. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 76.3%, for example, ranks in the top 40% globally. The market price is low relative to the book (accounting) value of the company's equity, which further promotes our neutral price/fair value ratio.
Economic moat
The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. Its moat is bolstered by its strong financial health, which indicates low near-term bankruptcy risk.
By Quantitative Equity Report
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.